SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-020639
Filing Date
2020-03-23
Accepted
2020-03-23 16:30:14
Documents
2
Period of Report
2020-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1622
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4604
  Complete submission text file 0001209191-20-020639.txt   7741
Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Issuer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1551 EASTLAKE AVENUE E STE 200 SEATTLE WA 98102
Business Address
Palaniappan Jyoti (Reporting) CIK: 0001807021 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38957 | Film No.: 20735213